Related News
New drug rules help terminally ill
BRITAIN'S health care cost-effectiveness watchdog has announced new rules for the approval of drugs that could give British people with terminal illnesses longer to live. A cancer support group said 10,000 patients a year could benefit from the rule change.
The National Institute for Health and Clinical Excellence (NICE) said on Friday the new guidelines would ensure that its independent advisory bodies fully considered all benefits when making recommendations on treatments that extend the life of patients who don't have long to live.
NICE decides which treatments are made available under Britain's state-funded National Health Service.
The new rules will give terminally ill patients access to treatments that, although shown to extend patients' lives, would normally be considered by NICE to be too expensive.
The National Institute for Health and Clinical Excellence (NICE) said on Friday the new guidelines would ensure that its independent advisory bodies fully considered all benefits when making recommendations on treatments that extend the life of patients who don't have long to live.
NICE decides which treatments are made available under Britain's state-funded National Health Service.
The new rules will give terminally ill patients access to treatments that, although shown to extend patients' lives, would normally be considered by NICE to be too expensive.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔$粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.